The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| Axcella Health Inc | COM | 05454B105 | 37,610 | 7,901,362 | SH | DFND | 2,3 | 0 | 7,901,362 | 0 | |
| Axcella Health Inc | COM | 05454B105 | 13,737 | 2,886,023 | SH | DFND | 3,4 | 0 | 2,886,023 | 0 | |
| Axcella Health Inc | COM | 05454B105 | 8,382 | 1,761,029 | SH | DFND | 3 | 0 | 1,761,029 | 0 | |
| Codiak Biosciences Inc | COM | 192010106 | 31,990 | 2,121,354 | SH | DFND | 1,3 | 0 | 2,121,354 | 0 | |
| Codiak Biosciences Inc | COM | 192010106 | 7,328 | 485,949 | SH | DFND | 3 | 0 | 485,949 | 0 | |
| Denali Therapeutics Inc | COM | 24823R105 | 155,898 | 2,730,263 | SH | DFND | 1,3 | 0 | 2,730,263 | 0 | |
| Evelo Biosciences Inc | COM | 299734103 | 109,197 | 10,205,282 | SH | DFND | 1,3 | 0 | 10,205,282 | 0 | |
| Evelo Biosciences Inc | COM | 299734103 | 50,110 | 4,683,213 | SH | DFND | 2,3 | 0 | 4,683,213 | 0 | |
| Evelo Biosciences Inc | COM | 299734103 | 44,142 | 4,125,461 | SH | DFND | 3,4 | 0 | 4,125,461 | 0 | |
| Evelo Biosciences Inc | COM | 299734103 | 14,664 | 1,370,476 | SH | DFND | 3,6 | 0 | 1,370,476 | 0 | |
| Evelo Biosciences Inc | COM | 299734103 | 28,308 | 2,645,637 | SH | DFND | 3 | 0 | 2,645,637 | 0 | |
| Foghorn Therapeutics Inc | COM | 344174107 | 122,981 | 9,330,878 | SH | DFND | 1,3 | 0 | 9,330,878 | 0 | |
| Foghorn Therapeutics Inc | COM | 344174107 | 19,657 | 1,491,441 | SH | DFND | 3,4 | 0 | 1,491,441 | 0 | |
| Foghorn Therapeutics Inc | COM | 344174107 | 24,407 | 1,851,801 | SH | DFND | 3,5 | 0 | 1,851,801 | 0 | |
| Kaleido Biosciences Inc | COM | 483347100 | 79,056 | 9,759,979 | SH | DFND | 1,3 | 0 | 9,759,979 | 0 | |
| Kaleido Biosciences Inc | COM | 483347100 | 13,999 | 1,728,309 | SH | DFND | 2,3 | 0 | 1,728,309 | 0 | |
| Kaleido Biosciences Inc | COM | 483347100 | 24,159 | 2,982,639 | SH | DFND | 3,4 | 0 | 2,982,639 | 0 | |
| Kaleido Biosciences Inc | COM | 483347100 | 5,980 | 738,333 | SH | DFND | 3,6 | 0 | 738,333 | 0 | |
| Kaleido Biosciences Inc | COM | 483347100 | 35,368 | 4,366,450 | SH | DFND | 3 | 0 | 4,366,450 | 0 | |
| Moderna Inc | COM | 60770K107 | 2,694,570 | 20,577,092 | SH | DFND | 2,3 | 0 | 20,577,092 | 0 | |
| Moderna Inc | COM | 60770K107 | 514 | 3,924 | SH | DFND | 3 | 0 | 3,924 | 0 | |
| Rubius Therapeutics Inc | COM | 78116T103 | 308,694 | 11,648,828 | SH | DFND | 1,3 | 0 | 11,648,828 | 0 | |
| Rubius Therapeutics Inc | COM | 78116T103 | 641,936 | 24,223,995 | SH | DFND | 2,3 | 0 | 24,223,995 | 0 | |
| Rubius Therapeutics Inc | COM | 78116T103 | 69,793 | 2,633,703 | SH | DFND | 3,4 | 0 | 2,633,703 | 0 | |
| Sana Biotechnology Inc | COM | 799566104 | 437,539 | 13,072,570 | SH | DFND | 1,3 | 0 | 13,072,570 | 0 | |
| Sana Biotechnology Inc | COM | 799566104 | 325,500 | 9,725,122 | SH | DFND | 3,7 | 0 | 9,725,122 | 0 | |
| Sana Biotechnology Inc | COM | 799566104 | 382,941 | 11,441,326 | SH | DFND | 3 | 0 | 11,441,326 | 0 | |
| Seres Therapeutics Inc | COM | 81750R102 | 174,045 | 8,452,876 | SH | DFND | 2,3 | 0 | 8,452,876 | 0 | |
| Seres Therapeutics Inc | COM | 81750R102 | 61,007 | 2,962,963 | SH | DFND | 3,7 | 0 | 2,962,963 | 0 | |
| Seres Therapeutics Inc | COM | 81750R102 | 67,085 | 3,258,134 | SH | DFND | 3,6 | 0 | 3,258,134 | 0 | |
| Sigilon Therapeutics Inc | COM | 82657L107 | 198,667 | 8,888,888 | SH | DFND | 1,3 | 0 | 8,888,888 | 0 | |
| Sigilon Therapeutics Inc | COM | 82657L107 | 33,111 | 1,481,481 | SH | DFND | 3,5 | 0 | 1,481,481 | 0 | |
| Syros Pharmaceuticals Inc | COM | 87184Q107 | 21,980 | 2,938,494 | SH | DFND | 2,3 | 0 | 2,938,494 | 0 | |